DMEMEDS shared post via Reuters: Study may open new options for younger women with breast cancer

CHICAGO (Reuters) - The estrogen-blocking drug Aromasin worked better than the long-standing therapy tamoxifen at keeping cancers from returning in younger women with early stage breast cancer, a finding that may change the way the patients are treated, U.S. researchers said on Sunday. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/viftVELUi9I/story01.htm

Read More